📊 Key Data
  • $55,000 grants awarded to two Neuroscience & Society Champions for patient advocacy and neuroethics.
  • Patient-centered design now influencing BCI development, shifting focus from clinical endpoints to real-world usability.
  • Neurotech Network and Brain Health Learning Network expanding public neuro-literacy across age groups.
🎯 Expert Consensus

Experts agree that integrating patient advocacy and neuroethics into neurotechnology development is essential for creating equitable, usable, and ethically sound innovations.

about 5 hours ago
Architects of the Mind: Patient Advocates Rewiring Neurotech

Architects of the Mind: Patient Advocates Rewiring Neurotech

NEW YORK, NY – November 16, 2026 — The neurotechnology sector is experiencing a historic surge in both capital and capability. With brain-computer interfaces (BCIs) transitioning from academic laboratories into commercial clinical trials, the race to decode human cognition is accelerating. Yet, as the industry pushes the boundaries of what is technically possible, a critical question remains: who is ensuring these innovations actually serve the people they are designed for?

The Dana Foundation, a private philanthropic organization dedicated to brain research, addressed this imperative today by naming Jennifer French, MBA, and Eric H. Chudler, Ph.D., as the recipients of its second annual Neuroscience & Society Champion Awards. Announced during the Society for Neuroscience annual meeting, the honor awards each recipient a $55,000 unrestricted grant. The recognition highlights a growing institutional movement toward integrating lived patient experiences, neuroethics, and public literacy directly into the design and regulation of cutting-edge brain research.

"Jennifer French and Eric Chudler clearly demonstrate how listening to people and incorporating their perspectives and experiences can shape neuroscience for the better," said Caroline Montojo, president and CEO of the Dana Foundation. "Through patient engagement, neuroscience outreach and education, and the integration of neuroethics, they have opened new paths for collaboration and helped more people participate in neuroscience and see its relevance to their lives. These awards recognize their leadership and support bold, creative ideas that strengthen neuroscience's benefits to society."

From Subject to Architect: Reshaping BCI Development

Historically, the development of invasive neural prosthetics has been driven by a top-down approach, prioritizing technical feasibility and laboratory performance over practical usability. Patients were often viewed merely as subjects in clinical trials rather than co-creators of the technology. Jennifer French is systematically dismantling this paradigm.

Living with tetraplegia following a spinal cord injury, French is an early user of an experimental implanted neural prosthesis. She brings an indispensable lived experience to her role as the founder and executive director of Neurotech Network, a nonprofit dedicated to neurotechnology education and advocacy. Her work is forcing a critical pivot in how BCIs are developed, shifting the industry's focus from purely clinical endpoints to patient-reported outcomes and real-world quality of life.

"For decades, engineers designed devices that looked spectacular on paper but failed to account for the daily realities of living with a severe disability," noted one medical device regulatory expert familiar with the shifting landscape. "Advocates with lived experience are now sitting at the table, demanding that usability, device longevity, and user autonomy are baked into the design process from day one."

French's influence extends deep into the regulatory frameworks governing this nascent industry. As a co-founder of the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC)—alongside prominent researchers Leigh Hochberg, M.D., Ph.D., and Jochen Lennerz, M.D., Ph.D.—she has helped create a vital conduit between diverse stakeholders and the Food and Drug Administration. The iBCI-CC participates in the FDA's Collaborative Communities program, providing consensus-driven input on regulatory pathways, data standards, and ethical trial designs. This active engagement ensures that as venture-backed neurotech startups race to market, they must navigate a regulatory environment that increasingly demands patient-centered design and robust ethical safeguards.

Democratizing the Brain: A Lifespan Approach to Public Neuroethics

As neurotechnology becomes more sophisticated, the ethical implications surrounding cognitive liberty, mental privacy, and algorithmic bias grow increasingly complex. Navigating this minefield requires an informed public capable of engaging critically with both the promises and perils of brain science. This is the domain of Dr. Eric H. Chudler, an associate professor emeritus in the University of Washington's department of bioengineering and executive director of the university's Center for Neurotechnology.

Chudler has dedicated his career to demystifying the brain. In 1997, he launched 'Neuroscience for Kids,' a foundational online platform that has introduced millions of K-12 students globally to basic neurobiology. By integrating neuroethics early into STEM education, Chudler has helped cultivate a generation of scientifically literate citizens equipped to question the societal impacts of emerging technologies.

However, the need for public neuroethics is not limited to the young. As the global population ages, cognitive decline and brain health have become critical public health concerns, accompanied by a surge in misinformation regarding neuro-enhancement and dementia prevention. Recognizing this gap, Chudler utilized a 2023 Dana Foundation grant to establish the Brain Health Learning Network. This initiative specifically targets older adults, providing evidence-based resources to help them make informed healthcare decisions and effectively communicate their concerns to medical providers.

"You cannot have a functional societal debate about neuro-rights or cognitive privacy if the general public lacks a fundamental understanding of how the brain works," observed an academic neuroethicist. "Programs that span the demographic spectrum, from grade school to elder care, are the only way to build a resilient, informed society capable of holding the neurotech industry accountable."

Philanthropy's Pivot: Betting on 'Neuroscience & Society'

The recognition of French and Chudler underscores a broader strategic pivot within scientific philanthropy. For decades, organizations like the Dana Foundation primarily funded basic bench science—the fundamental laboratory research necessary to understand neural mechanisms. While that research remains vital, there is a growing consensus that scientific discovery alone is insufficient. The new frontier is human-centered neuroscience, a paradigm that actively bridges the gap between the laboratory and the living room.

This shift is reflected in the structure of the Neuroscience & Society Champion Awards. By providing $55,000 in unrestricted grants, the foundation empowers bridge-builders with maximum flexibility. Unrestricted funding is famously rare in scientific grants, which typically require rigid project milestones. This financial agility allows advocates and educators to respond dynamically to emerging ethical crises, fund operational costs, or scale community outreach without the burden of traditional administrative red tape.

The strategy is clear: reward the integration of science and society. This builds upon the foundation's 2025 inaugural awards, which honored pioneers in neuroethics and neurolaw. By consistently funding leaders who navigate the intersection of brain science, legal systems, and ethical frameworks, philanthropic organizations are actively shaping an ecosystem where technological advancement is inextricably linked to social responsibility.

Navigating the Next Wave of Transformative Technologies

The commercial landscape for neurotechnology is highly competitive, with billions of dollars flowing into startups and established medical device conglomerates alike. As companies push forward with human trials for increasingly invasive neural interfaces, the risk of ethical missteps or technological misalignment with patient needs is profound.

The work championed by French and Chudler represents a critical de-risking mechanism for the entire industry. By establishing robust patient advocacy channels and fostering widespread public neuro-literacy, they are helping to create a market environment where co-creation is not just a buzzword, but a baseline requirement for commercial and regulatory success. Startups that ignore lived experience will increasingly find themselves at a disadvantage, facing higher regulatory hurdles and lower user adoption rates.

Ultimately, the rapid evolution of brain-computer interfaces and neuro-therapeutics holds the potential to eradicate devastating neurological conditions and fundamentally alter the human experience. Ensuring that this transformation is equitable, ethical, and genuinely beneficial requires more than just brilliant engineering. It requires the dedicated translation of complex science into human terms, a task that the newest Neuroscience & Society Champions have proven themselves uniquely equipped to handle.

Topics & Related

Event:
Industry Awards
Theme:
Philanthropy
Sector:
Medical Devices

📝 This article is still being updated

Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.

Contribute Your Expertise →
UAID: 55110